Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-02

Clinical Trial Update: CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study [NA]

View source ↗

Summary

This document reports a pivotal trial evaluating the Cor TRICUSPID ECM Valve Replacement, with the study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cor TRICUSPID ECM Valve Replacement

Snippet

Sponsor: Corvivo Cardiovascular, Inc. | Conditions: Tricuspid Valve Disease, Tricuspid Valve Insufficiency | NA | Status: RECRUITING